Piramal Pharma bets on US biopharma funding uptick to lift growth
Published on: Nov. 6, 2025, 5:54 p.m. | Source: Livemint
CDMO slowdown dragged Q2FY26 revenues, but Piramal Pharma management expects a rebound in US biopharma funding to boost growth in the next two years.
